Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ganetespib with Carboplatin and Niraparib in Ovarian Cancer
NCT03783949Phase 2Completed
- Sponsor
- UZ Leuven
- Start
- Nov 2018
- Primary completion
- Sep 2023
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 2 trial of ganetespib in ovarian cancer, fallopian tube cancer (PFTC), primary peritoneal carcinoma (PPC), sponsored by UZ Leuven. Started Nov 2018; status: completed.
02
Drugs
ganetespib
03
Conditions
ovarian cancerfallopian tube cancer (PFTC)primary peritoneal carcinoma (PPC)
Beyond the preview
Go deeper on NCT03783949.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03783949.